SilverHawk (TM) Peripheral Plaque Excision System: percutaneous peripheral atherectomy for patients with peripheral vascular disease
Parrella, A, Hiller, JE, Mundy, L
Record ID 32006000652
English
Authors' results and conclusions:
Cardiovascular disease is Australia's leading cause of morbidity and mortality and represents a significant economic burden on public health funding. There is currently limited, low-level evidence available that demonstrates that the SilverHawk may decrease the health and economic burden associated with peripheral vascular disease in the long-term. Furthermore, there are no studies comparing the device with other endovascular therapies.
Authors' recommendations:
Until randomised studies are conducted that compare the SilverHawk with other directional arethectomy procedures and/or other endovascular therapies, it is recommended that this technology be monitored.
Details
Project Status:
Completed
Year Published:
2005
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Arterial Occlusive Diseases
- Atherectomy
- Peripheral Vascular Diseases
Keywords
- Arterial Occlusive Disease
- Atherectomy
- Femoral Artery
- Peripheral Vascular Diseases
- Popliteal Artery
- Vascular Patency
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.